Purchase this article with an account.
Yuichi Uchino; The Ocular Surface Glycocalyx and its Alteration in Dry Eye Disease: A Review. Invest. Ophthalmol. Vis. Sci. 2018;59(14):DES157-DES162. doi: 10.1167/iovs.17-23756.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Many studies have revealed that transmembrane mucins, large glycoproteins with heavily glycosylated glycans, are essential for maintaining ocular surface epithelium lubrication and wettability. Recent reports indicate that transmembrane mucins and galectin-3, a chimera type of galectin that binds β-galactoside in the glycan, play a crucial role in maintaining the epithelial glycocalyx barrier. This review summarizes current evidence regarding the role of galectin-3, the role of the three major transmembrane mucins (i.e., MUC1, MUC4, and MUC16), in the maintenance of ocular surface wettability and transcellular barrier. Pathological mechanisms of glycocalyx barrier disruption and epithelial surface wettability decreases in dry eye disease are also summarized. Lastly, new ophthalmic drugs that target transmembrane mucin are described.
This PDF is available to Subscribers Only